A detailed history of California State Teachers Retirement System transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 106,293 shares of ARWR stock, worth $2.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
106,293
Previous 120,675 11.92%
Holding current value
$2.38 Million
Previous $3.14 Million 34.41%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$19.36 - $29.54 $278,435 - $424,844
-14,382 Reduced 11.92%
106,293 $2.06 Million
Q2 2024

Aug 14, 2024

SELL
$21.87 - $28.24 $39,606 - $51,142
-1,811 Reduced 1.48%
120,675 $3.14 Million
Q1 2024

May 15, 2024

BUY
$27.21 - $39.48 $411,850 - $597,569
15,136 Added 14.1%
122,486 $3.5 Million
Q4 2023

Feb 13, 2024

SELL
$21.2 - $31.03 $101,399 - $148,416
-4,783 Reduced 4.27%
107,350 $3.28 Million
Q3 2023

Nov 14, 2023

SELL
$26.2 - $36.08 $327,814 - $451,432
-12,512 Reduced 10.04%
112,133 $3.01 Million
Q2 2023

Aug 21, 2023

SELL
$25.16 - $41.38 $53,364 - $87,766
-2,121 Reduced 1.67%
124,645 $4.44 Million
Q1 2023

May 09, 2023

SELL
$23.68 - $38.51 $46,602 - $75,787
-1,968 Reduced 1.53%
126,766 $3.22 Million
Q4 2022

Feb 14, 2023

BUY
$28.0 - $40.56 $46,340 - $67,126
1,655 Added 1.3%
128,734 $5.22 Million
Q3 2022

Nov 18, 2022

SELL
$29.63 - $48.31 $66,726 - $108,794
-2,252 Reduced 1.74%
127,079 $4.2 Million
Q2 2022

Aug 15, 2022

BUY
$27.79 - $50.61 $17,730 - $32,289
638 Added 0.5%
129,331 $4.55 Million
Q1 2022

May 16, 2022

SELL
$39.62 - $69.97 $408,640 - $721,670
-10,314 Reduced 7.42%
128,693 $5.92 Million
Q4 2021

Feb 15, 2022

BUY
$58.09 - $82.51 $187,746 - $266,672
3,232 Added 2.38%
139,007 $9.22 Million
Q3 2021

Nov 15, 2021

SELL
$58.38 - $84.96 $228,732 - $332,873
-3,918 Reduced 2.8%
135,775 $8.48 Million
Q2 2021

Aug 16, 2021

SELL
$62.15 - $90.32 $914,661 - $1.33 Million
-14,717 Reduced 9.53%
139,693 $11.6 Million
Q1 2021

May 18, 2021

BUY
$61.35 - $90.47 $158,712 - $234,045
2,587 Added 1.7%
154,410 $10.2 Million
Q4 2020

Feb 16, 2021

SELL
$43.82 - $85.37 $4,294 - $8,366
-98 Reduced 0.06%
151,823 $11.6 Million
Q3 2020

Nov 17, 2020

BUY
$33.21 - $51.27 $19,029 - $29,377
573 Added 0.38%
151,921 $6.54 Million
Q2 2020

Aug 17, 2020

SELL
$26.12 - $43.27 $21,209 - $35,135
-812 Reduced 0.53%
151,348 $6.54 Million
Q1 2020

May 13, 2020

BUY
$20.56 - $63.12 $196,060 - $601,912
9,536 Added 6.69%
152,160 $4.38 Million
Q4 2019

Feb 14, 2020

SELL
$28.14 - $73.01 $89,907 - $233,266
-3,195 Reduced 2.19%
142,624 $9.05 Million
Q3 2019

Nov 15, 2019

BUY
$26.26 - $34.86 $53,885 - $71,532
2,052 Added 1.43%
145,819 $4.11 Million
Q2 2019

Aug 14, 2019

BUY
$17.43 - $28.82 $7,059 - $11,672
405 Added 0.28%
143,767 $3.81 Million
Q1 2019

May 09, 2019

BUY
$12.05 - $20.18 $84,735 - $141,905
7,032 Added 5.16%
143,362 $2.63 Million
Q4 2018

Feb 13, 2019

BUY
$10.74 - $19.7 $32,842 - $60,242
3,058 Added 2.29%
136,330 $1.69 Million
Q3 2018

Nov 14, 2018

BUY
$14.0 - $20.3 $868 - $1,258
62 Added 0.05%
133,272 $2.56 Million
Q2 2018

Aug 14, 2018

BUY
$6.37 - $14.02 $848,547 - $1.87 Million
133,210 New
133,210 $1.81 Million

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.37B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.